The testimony came as the Trump administration continues to purge inspectors general across sectors of the federal government.
The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) unveiled a four-pronged strategic plan to oversee the nation’s continuing fight against the COVID-19 virus this week, coinciding with the agency’s acting chief providing testimony before Congress in the wake of President Trump’s announcement that he intended to replace her following the release of a controversial report on hospital preparedness for the pandemic.
HHS Principal Deputy Inspector General Christi A. Grimm told members of the U.S. House of Representatives Oversight Committee that her agency is proceeding with 14 separate projects currently underway to track the administration’s response to the pandemic.
“I personally and professionally cannot let the idea of providing unpopular information drive decision-making in the work that we do,” Grimm said during videotaped testimony delivered remotely. “We are plowing ahead.”
The strategic plan was not a primary focus of Grimm’s testimony, although she did touch on elements of it. A seven-page overview of the plan released by HHS OIG, with three of those pages featuring little text, briefly outlined four specific aims: to “protect people, protect funds, protect infrastructure,” and “promote effectiveness.”
Those four goals encompassed eight objectives, including the following:
“OIG is using risk assessment and data analytics to identify, monitor, and target potential fraud, waste, and abuse affecting HHS programs and beneficiaries and to promote the effectiveness of HHS’s COVID-19 response and recovery programs,” the plan’s introduction read. “We use expert staff and modern tools and technologies, including artificial intelligence, to detect trends and patterns of suspicious activity, and to shape and strengthen our oversight and enforcement. As appropriate and feasible, we share data analytics and technical assistance with HHS officials to strengthen program integrity, effectiveness, and management practices. Further, we are coordinating our work with key oversight and law enforcement partners, including the Pandemic Response Accountability Committee (PRAC); Federal, State, local, and Tribal entities; and the Government Accountability Office, among others, to ensure adequate oversight, avoid duplication, and share insights.”
More specifically, Grimm said during her testimony, those efforts include a newly announced audit into $50 billion that HHS is distributing to providers nationwide.
Trump’s intention to nominate a Boston-area assistant United States attorney to replace Grimm, along with several similar recent moves to oust inspectors general across other federal agencies, comprised the backdrop of her testimony, with Oversight Chair Carolyn Maloney (D-New York) reportedly noting that “it is our responsibility to protect the IGs from political interference.” As Grimm testified, in fact, yet another such official – the Pentagon’s top watchdog, Glenn Fine – announced his resignation.
The move to dismiss Grimm came a little less than a month after her office issued a scathing 41-page report outlining daunting logistical struggles faced by hospitals as the pandemic worsened in the U.S. earlier this year. NPR reported at the time that HHS did not offer comment on Grimm’s future role within the agency, but instead said in a statement that the agency had been preparing “to assist a new Inspector General appointee over a year ago, when the previous presidentially appointed and Senate-confirmed Inspector General first announced his intention to retire from government service. We will continue to work conscientiously to support a smooth leadership transition.”
The statement appeared to reference former HHS Inspector General Dan Levinson, a George W. Bush appointee who retired last year. In fact, Levinson, a frequent guest on Monitor Mondays Internet radio broadcast, was among the first to come to Grimm’s defense when criticism of her report arose, labeling her “a highly respected career senior executive” and adding that “nothing in her longstanding career of public service would suggest otherwise.”
Grimm’s report, titled Hospital Experiences Responding to the COVID-19 Pandemic, was based on surveys of hospital administrators from 323 hospitals across 46 states who were posed three open-ended questions from March 23-27, centering on a) the most difficult challenges experienced thus far in responding to COVID-19; b) what strategies hospitals are using to address or mitigate those challenges; and c) how government could best support hospitals responding to COVID-19.
One hospital administrator said that nationwide, “millions (of tests) are needed, and we only have hundreds.” Another said that waits of a week and longer for test results contrasted unfavorably with the fact that “24 hours would typically be considered a long turnaround” for testing for other viruses. Among hospital administrators that had received supplies from the national stockpile, one said that 500 delivered masks were designed for children and did not fit adults; another found a supply of masks unusable because their elastic bands had dry-rotted; still another received PPE with an expiration date of 2010.
As of Wednesday, the global COVID-19 pandemic had reportedly infected more than 5.7 million people around the world, resulting in more than 350,000 deaths, including more than 1.7 million Americans, approximately 100,000 of whom have died.
To read the HHS OIG strategic plan in its entirety, go online to https://oig.hhs.gov/about-oig/strategic-plan/COVID-OIG-Strategic-Plan.pdf.
Back in June, I was on the Monitor Mondays broadcast discussing the initial momentum within the Trump Administration for a single, national provider directory. Now,
It’s no secret to any of us that there has been quite a bit of recent disagreement between the opposing sides of the political aisle
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
